GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (OTCPK:DGNOF) » Definitions » EV-to-FCF

Diagnos (Diagnos) EV-to-FCF

: -12.66 (As of Today)
View and export this data going back to 2000. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Diagnos's Enterprise Value is $19.05 Mil. Diagnos's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.51 Mil. Therefore, Diagnos's EV-to-FCF for today is -12.66.

The historical rank and industry rank for Diagnos's EV-to-FCF or its related term are showing as below:

DGNOF' s EV-to-FCF Range Over the Past 10 Years
Min: -28.67   Med: -6.44   Max: -1.24
Current: -12.79

During the past 13 years, the highest EV-to-FCF of Diagnos was -1.24. The lowest was -28.67. And the median was -6.44.

DGNOF's EV-to-FCF is ranked worse than
100% of 363 companies
in the Healthcare Providers & Services industry
Industry Median: 20.32 vs DGNOF: -12.79

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-18), Diagnos's stock price is $0.2224. Diagnos's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.029. Therefore, Diagnos's PE Ratio for today is At Loss.


Diagnos EV-to-FCF Historical Data

The historical data trend for Diagnos's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.75 -3.93 -25.34 -8.52 -13.82

Diagnos Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.49 -13.82 -16.06 -21.64 -16.31

Competitive Comparison

For the Health Information Services subindustry, Diagnos's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnos EV-to-FCF Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Diagnos's EV-to-FCF falls into.



Diagnos EV-to-FCF Calculation

Diagnos's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=19.054/-1.505
=-12.66

Diagnos's current Enterprise Value is $19.05 Mil.
Diagnos's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnos  (OTCPK:DGNOF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Diagnos's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.2224/-0.029
=At Loss

Diagnos's share price for today is $0.2224.
Diagnos's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.029.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Diagnos EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Diagnos's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos (Diagnos) Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, UAE, Saudi Arabia, Mexico, Costa Rica, and others. The company's key revenue is derived from Canada.

Diagnos (Diagnos) Headlines

From GuruFocus

DIAGNOS Announces Corporate Reorganization

By GlobeNewswire GlobeNewswire 03-11-2019

DIAGNOS Announces Closing of Private Placement

By GlobeNewswire GlobeNewswire 11-25-2022

DIAGNOS Announces Final Closing of Private Placement

By GlobeNewswire GlobeNewswire 11-21-2018